| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/03/2008 | US7381817 LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus |
| 06/03/2008 | US7381809 Compositions and methods for the treatment of immune related diseases |
| 06/03/2008 | US7381804 A colony-stimulating factor hybrid molecules, computer analyzing the three dimensional structure protein, crystallization of the protein |
| 06/03/2008 | US7381802 Human antibodies that specifically recognize the toxin Cn2 from Centruroides noxius scorpion venom |
| 06/03/2008 | US7381800 Antibodies to HBIMF63 polypeptide |
| 06/03/2008 | US7381798 binds to 2,3,4,7,8-pentachlorodibenzofuran; expression vectors; simple, rapid and sensitive |
| 06/03/2008 | US7381795 Modified interferon beta with reduced immunogenicity |
| 06/03/2008 | US7381794 Dimeric fusion proteins and materials and methods for producing them |
| 06/03/2008 | US7381712 In vivo transfection in avians |
| 06/03/2008 | US7381560 Administering a chimeric anti-CD20 antibody; hybridomas; monoclonal antibodies |
| 06/03/2008 | US7381554 UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R/N-acetylglucosamine-β1,3-N-acetylgalactosamine-α-R (GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2/4GnT |
| 06/03/2008 | US7381545 Method for controlling metallophosphate precipitation in high cell density fermentations |
| 06/03/2008 | US7381544 Nucleic acid that encodes a fusion protein |
| 06/03/2008 | US7381543 TAB1 protein and DNA coding therefore |
| 06/03/2008 | US7381412 Monoclonal antibody for use in diagnosis, prevention and treatment of inflammatory disorders |
| 06/03/2008 | US7381411 Preventing influenza virus cell binding; schizophrenia; diagnosing chronic viral disease associated with cancer development |
| 06/03/2008 | US7381410 Monoclonal antibodies that bind to epitope and inhibit clustering or phosphorylation between EphB4 and Ephrin B2 |
| 06/03/2008 | US7381408 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 06/03/2008 | CA2558659C Genetically engineered canary poxvirus-based vaccine strain |
| 06/03/2008 | CA2408447C Novel gene controlling disease resistance reactions and use thereof |
| 06/03/2008 | CA2404046C Improved methods and cells for expression of recombinant protein products |
| 06/03/2008 | CA2264962C Transcription factor controlling phenylpropanoid biosynthesis pathway |
| 06/03/2008 | CA2261018C Treatment and diagnosis of cancer |
| 06/03/2008 | CA2244083C Production of bacillus thuringiensis integrants |
| 06/03/2008 | CA2220563C Protein production in transgenic alfalfa plants |
| 06/03/2008 | CA2186269C Wound healing |
| 06/03/2008 | CA2185339C Enhanced expression in a plant plastid |
| 05/29/2008 | WO2008063302A2 Novel p. pastoris pastoris promoters, and the use thereof to direct expression of proteins in yeast, preferably using a haploid mating strategy |
| 05/29/2008 | WO2008063291A2 Polypeptide ligands for targeting cartilage and methods of use thereof |
| 05/29/2008 | WO2008062904A1 Method of enabling stable expression of transgene |
| 05/29/2008 | WO2008062248A1 In-vitro pearl production using marine organisms |
| 05/29/2008 | WO2008062063A1 Novel antiproliferation antibodies |
| 05/29/2008 | WO2008037265A3 Method of fed-batch cultivation and recombinant protein expression in escherichia coli bl21(de3) in deuterated medium |
| 05/29/2008 | WO2007067828A9 Glp-2 mimetibodies, polypeptides, compositions, methods and uses |
| 05/29/2008 | WO2006137597A9 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances |
| 05/29/2008 | WO2006083301A3 Immunogenic compositions comprising hmgb1 polypeptides |
| 05/29/2008 | US20080127371 Genes encoding 4-hydroxyphenylpyruvate dioxygenase (hppd) enzymes for plant metabolic engineering |
| 05/29/2008 | US20080127368 Enhancing insect resistance in plants via modifying scent protein expression; biological pest control; disease resistant plants |
| 05/29/2008 | US20080127359 Using transgenic cells as bioreactors for immunoglobulin production |
| 05/29/2008 | US20080125576 Protein isolation |
| 05/29/2008 | US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 05/29/2008 | US20080125369 Soluble t cell receptors |
| 05/29/2008 | US20080125347 Use of host cells in forming modified target molecules, including therapeutic molecules having non-natural amino acids in their sequence; biosynthesis; drug conjugates |
| 05/29/2008 | US20080124798 Using plant cell as bioreactor for production of glycosyltransferase |
| 05/29/2008 | US20080124792 Modified retroviral regulatory sequence for use as gene transfer tool in genetic engineering |
| 05/29/2008 | US20080124786 Expression vector comprising nucleotide sequences coding diacylglycerol acyltransferases for use in enhancing omega fatty acids production in yarrowia |
| 05/29/2008 | US20080124766 Solid support comprising metal substrate for propagation of osteoblasts tissues; prosthetics and tissue engineering |
| 05/29/2008 | US20080124765 Using microbial cells as biorecators for synthesis of immunologically active peptide fragments |
| 05/29/2008 | US20080124764 Heterologous alpha amylase expression in aspergillus |
| 05/29/2008 | US20080124763 Constructs and methods for expression of recombinant proteins in methylotrophic yeast cells |
| 05/29/2008 | US20080124762 Expression vector comprising nucleotide sequences coding epstein Barr virus nuclear antigen-1 (EBNA-1) protein for use in large-scale transient expression of modified polypeptides; improving heterologous gene expression |
| 05/29/2008 | US20080124761 Nutrient broth comprising fish meat enzymatic degradation product for use in propagation of cells and expression of preferential protein products |
| 05/29/2008 | US20080124760 Regulatory Nucleic Acid Elements |
| 05/29/2008 | US20080124759 Novel fgf homolog zfgf12 |
| 05/29/2008 | US20080124757 Used in antibacterial, immunosuppressant, and antitumor drug making; loading an extender molecule on an acyl carrier protein (ACP) domain |
| 05/29/2008 | US20080124756 Light utilization alteration of photosynthetic microorganisms |
| 05/29/2008 | US20080124739 Compositions and methods for the diagnosis and treatment of tumor |
| 05/29/2008 | US20080124427 Process for preparing a dough comprising a starch-degrading glucogenic exo-amy-lase of family 13 |
| 05/29/2008 | US20080124361 consisting essentially of: a flagellin adjuvant comprising, consisting of, or consisting essentially of a flagellin N-terminal constant region; a flagellin C-terminal constant region; and a Yersinia pestis antigen between the N-terminal constant region and the C-terminal constant region |
| 05/29/2008 | US20080124353 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124351 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124340 Erythropoietin receptor agonists |
| 05/29/2008 | US20080124339 Monoclonal antibody specific to mucosal addressin cell adhesion molecule (MAdCAM) for use in prevention and treatment of inflammatory, gastrointestinal, liver disorders |
| 05/29/2008 | US20080124337 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics |
| 05/29/2008 | US20080124336 Molecules and Methods for Inhibiting Shedding of KIM-1 |
| 05/29/2008 | US20080124330 Monoclonal antibody for use in treatment and prevention of cell proliferative disorders; tissue targeted therapy |
| 05/29/2008 | US20080124313 Nucleotide sequences coding methionyl tRNA synthetase protein for use in identifying modulators for prevention and treatment of bacterial infection |
| 05/29/2008 | US20080124284 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis |
| 05/29/2008 | US20080124278 characterized by a modification at the conserved N-linked site in the CH2 domains of the Fc portion of said antibody; useful in the treatment and prevention of diseases that involve undesirable immune responses |
| 05/29/2008 | CA2670389A1 Transgenic animal with enhanced immune response and method for the preparation thereof |
| 05/29/2008 | CA2670039A1 Novel antiproliferation antibodies |
| 05/28/2008 | EP1925670A1 Escherichia coli expression vector and the uses thereof |
| 05/28/2008 | EP1925666A1 Human Toll-like receptor proteins, related reagents and methods |
| 05/28/2008 | EP1925663A1 Two-steps enzyme method for preparing 7-aminocephalosporanic acid |
| 05/28/2008 | EP1925662A1 Recombinant Poxvirus-Cytomegalovirus Compositions and uses |
| 05/28/2008 | EP1925320A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 05/28/2008 | EP1924682A1 Semi-continuous fermentation process |
| 05/28/2008 | EP1924601A1 Expression of proteins in e.coli |
| 05/28/2008 | EP1786917A4 Optimized interferon-beta gene |
| 05/28/2008 | EP1377251B1 A cell therapy method for the treatment of tumors |
| 05/28/2008 | EP1307582B1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 05/28/2008 | EP1246845B1 Method for making insulin precursors and insulin precursor analogs |
| 05/28/2008 | EP1148125B1 Human nucleoprotein having a ww domain and polynucleotide encoding the same |
| 05/28/2008 | EP1032668B1 Fibroblast growth factor-19 |
| 05/28/2008 | EP0998496B1 Isolated dendritic cell membrane protein genes |
| 05/28/2008 | EP0968295B1 Vectors having enhanced expression and methods of making and uses thereof |
| 05/28/2008 | EP0963435B1 Methods for production of proteins |
| 05/28/2008 | EP0766825B1 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions |
| 05/28/2008 | CN101186942A Method for preparing mannatide |
| 05/28/2008 | CN101186941A Method for preparing high-purity mannatide |
| 05/28/2008 | CN101186940A Process for obtaining insulin or insulin derivatives having correctly bonded cystine bridges |
| 05/28/2008 | CN101186908A In vitro differential cutting of fusion protein by recombination plum pox virus NIa proteinase |
| 05/28/2008 | CN101186904A Novel peptide-forming enzyme gene |
| 05/28/2008 | CN101186903A Novel peptide-forming enzyme gene |
| 05/28/2008 | CN101186650A Antibody against secreted N-terminal peptide or C-terminal peptide of GPC3 present in blood |
| 05/28/2008 | CN101185706A Hippophae rhamnoides nutrition mixture with delaying senility function and preparation technique thereof |
| 05/28/2008 | CN100390289C Method for producing influenza hemagglutinin multivalent vaccines |
| 05/28/2008 | CN100390288C Multivalent antibodies and uses therefor |
| 05/28/2008 | CN100390286C Novel enzyme gene and its expression product |
| 05/28/2008 | CN100390281C Method for preparing physiologically active IL-18 polypeptide |